StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
001323.SZ$21.03+3.34%
Fair $21.03+0.0%

001323.SZ

De Rucci Healthy Sleep Co., Ltd.

Consumer Cyclical / Furnishings, Fixtures & AppliancesShenzhen

$21.03

+0.68 (+3.34%)

Fairly Valued+0.0%Fair Value $21.03Fund rank 30/100 · Data gapFallback financials|
SA 32/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $709.8M · quality 54.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 35/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 001323.SZLocal privado en este navegador · De Rucci Healthy Sleep Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9.1B

P/E

18.3x

↑

EV/EBITDA

10.3x

↑

ROE

12.1%

↑

Gross Margin

51.3%

↑

Debt/Equity

0.30

↓
52-Week Range$21
$20$31

TradingView lightweight chart

001323.SZ price, volumen y niveles de valoración

Último $21.03Periodo -58.7%
Fair value: $21.03

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-3.5%

FCF CAGR

+84.7%

FCF margin

3.1%

FCF / Net income

0.30x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.23B · net income $535.5M · FCF $162.0M

2022-FY → 2025-FY

Gross margin

51.3%+4.9% pts

Operating margin

9.8%-3.3% pts

Net margin

10.2%-1.9% pts

FCF margin

3.1%+2.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$5.23B$5.23B$5.60B$5.58B$5.81B
Net Income$535.5M$535.5M$767.3M$802.3M$708.4M
EBITDA$900.8M$900.8M$1.17B$1.20B$1.08B
EPS1.241.241.771.831.69
Gross Margin51.3%51.3%50.1%50.3%46.5%
Operating Margin9.8%9.8%15.6%16.0%13.1%
Net Margin10.2%10.2%13.7%14.4%12.2%
Balance Sheet
Debt/Equity0.300.300.240.110.02
Current Ratio1.491.49———
Cash Flow
Free Cash Flow$162.0M$162.0M$709.8M$1.54B$25.7M
Returns
ROE12.1%12.1%17.0%17.3%16.2%
Valuation
P/E18.2918.2919.7614.8419.35
EV/EBITDA10.2610.2612.687.9611.13
P/B2.052.053.362.573.14
Growth & Yield
Revenue Growth-6.7%-6.7%0.4%-4.0%—
EPS Growth-29.9%-29.9%-3.1%8.1%—
Dividend Yield6.9%6.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

14.6%

razonable

EPS terminal req.

$1.87

Spread vs growth

-44.5%

5Y implied EPS CAGR

12.7%

razonable

EPS terminal req.

$2.26

Spread vs growth

-42.7%

10Y implied EPS CAGR

11.4%

razonable

EPS terminal req.

$3.64

Spread vs growth

-41.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -20.8%

Total return

-20.8%

Start / end P/E

16.4x → 17.0x

EPS bridge

1.77 → 1.24

Residual

-1.0%

EPS growth-29.9%
Multiple rerating+3.2%
Dividend+6.9%
Residual / FX / buybacks / cross-term-1.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.